Reports for HOFFMANN-LA ROCHE LIMITED

Company Name

HOFFMANN-LA ROCHE LIMITED

Totals

Shortage reports

20
Actual shortage: 0 (0%)
Anticipated shortage: 0 (0%)
Avoided shortage: 7 (35%)
Resolved: 13 (65%)

Discontinuation Reports

16
To be discontinued: 3 (19%)
Discontinued: 13 (81%)
Reversed: 0 (0%)

Late reports

4 (11%)

Overdue reports

3 (100%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 21 to 20 of 20

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ESBRIET 267MG TABLET Discontinued 2023-08-03 2023-08-03 200955
ESBRIET 267MG CAPSULE Discontinued 2023-08-03 2023-08-03 200961
ESBRIET 267MG CAPSULE Discontinued 2023-08-03 2023-08-03 200964
FUZEON 108MG POWDER FOR SOLUTION To be discontinued 2024-10-07 2024-10-07 239548
GAVRETO 100MG CAPSULE To be discontinued 2024-11-06 2025-01-08 242142
INVIRASE 500MG TABLET Discontinued 2021-01-20 2021-01-20 132101
INVIRASE - CAP 200MG 200MG CAPSULE To be discontinued 2018-06-28 2018-06-28 53093
LECTOPAM TAB 3MG 3MG TABLET Discontinued 2017-08-29 2018-04-03 20572
LECTOPAM TAB 6MG 6MG TABLET Discontinued 2017-08-28 2018-04-03 20448
NUTROPIN AQ NUSPIN 10 10MG SOLUTION Discontinued 2024-07-03 2025-02-01 232079
NUTROPIN AQ NUSPIN 20 20MG SOLUTION Discontinued 2024-07-03 2025-02-01 232086
NUTROPIN AQ NUSPIN 5 5MG SOLUTION Discontinued 2024-07-03 2025-02-01 232071
NUTROPIN AQ PEN CARTRIDGE 10MG SOLUTION Discontinued 2017-06-30 2018-01-04 14451
TARCEVA 25MG TABLET Discontinued 2024-07-19 2024-10-02 233440
TARCEVA 100MG TABLET Discontinued 2024-07-19 2024-10-02 233443
TARCEVA 150MG TABLET Discontinued 2024-07-19 2024-10-02 233446

Showing 1 to 16 of 16